Increasingly complex: EMA's take on new drug applications
This article was originally published in SRA
Executive Summary
The European Medicines Agency says that while it has received a stable number of initial marketing authorization applications (MAAs) for human medicines, with a total of 96 applications received in 2012, it has observed an "increasing complexity" in the applications1.